Athena Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Sell
4,709
-749
-14% -$60.4K 0.22% 95
2026
Q1
$473K Hold
5,458
0.25% 95
2025
Q4
$524K Hold
5,458
0.27% 88
2025
Q3
$520K Hold
5,458
0.27% 89
2025
Q2
$476K Hold
5,458
0.27% 91
2025
Q1
$490K Sell
5,458
-30
-0.5% -$2.68K 0.3% 80
2024
Q4
$438K Hold
5,488
0.25% 93
2024
Q3
$494K Hold
5,488
0.28% 82
2024
Q2
$432K Hold
5,488
0.26% 89
2024
Q1
$478K Hold
5,488
0.29% 80
2023
Q4
$452K Hold
5,488
0.29% 79
2023
Q3
$430K Hold
5,488
0.31% 75
2023
Q2
$483K Hold
5,488
0.33% 70
2023
Q1
$442K Buy
5,488
+148
+3% +$12.1K 0.32% 72
2022
Q4
$415K Sell
5,340
-148
-3% -$12K 0.3% 78
2022
Q3
$443K Hold
5,488
0.37% 64
2022
Q2
$493K Hold
5,488
0.39% 57
2022
Q1
$610K Buy
+5,488
New +$580K 0.47% 53

Other funds holding MDT

Athena Investment Management's MDT Position: Q2 2026 in Review

Athena Investment Management reduced its Medtronic (MDT) stake by 14% in Q2 2026, selling an estimated $60.4K and leaving 4,709 shares worth $368K. The position accounts for 0.22% of the portfolio, ranked #95.

Athena Investment Management first reported a position in MDT in Q1 2022 and has held it in 18 quarters since. The position peaked at $610K in Q1 2022. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Athena Investment Management held 4,709 shares of Medtronic worth $368K as of Q2 2026.
  • Athena Investment Management sold 749 Medtronic shares in Q2 2026, an estimated $60.4K.
  • Medtronic made up 0.22% of Athena Investment Management's portfolio in Q2 2026, its #95 holding.
  • Athena Investment Management first reported a position in Medtronic in Q1 2022 and has held it in 18 quarters since.
  • Athena Investment Management's Medtronic position peaked at $610K in Q1 2022.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Athena Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.